Literature DB >> 21863020

Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases.

Andreas Strasser1, Suzanne Cory, Jerry M Adams.   

Abstract

Apoptosis, the major form of programmed cell death in metazoan organisms, plays critical roles in normal development, tissue homeostasis and immunity, and its disturbed regulation contributes to many pathological states, including cancer, autoimmunity, infection and degenerative disorders. In vertebrates, it can be triggered either by engagement of 'death receptors' of the tumour necrosis factor receptor family on the cell surface or by diverse intracellular signals that act upon the Bcl-2 protein family, which controls the integrity of the mitochondrial outer membrane through the complex interactions of family members. Both pathways lead to cellular demolition by dedicated proteases termed caspases. This review discusses the groundbreaking experiments from many laboratories that have clarified cell death regulation and galvanised efforts to translate this knowledge into novel therapeutic strategies for the treatment of malignant and perhaps certain autoimmune and infectious diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21863020      PMCID: PMC3173800          DOI: 10.1038/emboj.2011.307

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  217 in total

Review 1.  Delivering the kiss of death.

Authors:  Christina M Trambas; Gillian M Griffiths
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

2.  Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

Authors:  John R Jeffers; Evan Parganas; Youngsoo Lee; Chunying Yang; JinLing Wang; Jennifer Brennan; Kirsteen H MacLean; Jiawen Han; Thomas Chittenden; James N Ihle; Peter J McKinnon; John L Cleveland; Gerard P Zambetti
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

3.  Critical role for DP5/Harakiri, a Bcl-2 homology domain 3-only Bcl-2 family member, in axotomy-induced neuronal cell death.

Authors:  Kazunori Imaizumi; Adalberto Benito; Sumiko Kiryu-Seo; Victor Gonzalez; Naohiro Inohara; Andrew P Lieberman; Hiroshi Kiyama; Gabriel Nuñez; Andrew P Leiberman
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

4.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

5.  p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa.

Authors:  Andreas Villunger; Ewa M Michalak; Leigh Coultas; Franziska Müllauer; Gunther Böck; Michael J Ausserlechner; Jerry M Adams; Andreas Strasser
Journal:  Science       Date:  2003-09-18       Impact factor: 47.728

6.  VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

Authors:  Alexander Egle; Alan W Harris; Mary L Bath; Lorraine O'Reilly; Suzanne Cory
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

7.  Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death.

Authors:  Leigh Coultas; Philippe Bouillet; Edouard G Stanley; Thomas C Brodnicki; Jerry M Adams; Andreas Strasser
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  Integral role of Noxa in p53-mediated apoptotic response.

Authors:  Tsukasa Shibue; Kiyoshi Takeda; Eri Oda; Hiroshi Tanaka; Hideki Murasawa; Akinori Takaoka; Yasuyuki Morishita; Shizuo Akira; Tadatsugu Taniguchi; Nobuyuki Tanaka
Journal:  Genes Dev       Date:  2003-09-02       Impact factor: 11.361

9.  Haploinsufficiency of Bcl-x leads to male-specific defects in fetal germ cells: differential regulation of germ cell apoptosis between the sexes.

Authors:  Shinya Kasai; Shinichiro Chuma; Noboru Motoyama; Norio Nakatsuji
Journal:  Dev Biol       Date:  2003-12-01       Impact factor: 3.582

10.  Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells.

Authors:  Anselm Enders; Philippe Bouillet; Hamsa Puthalakath; Yuekang Xu; David M Tarlinton; Andreas Strasser
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

View more
  216 in total

1.  Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.

Authors:  A Mansour; M Nabil; R Ali-Labib; H Said; F Annos
Journal:  Med Oncol       Date:  2011-12-08       Impact factor: 3.064

Review 2.  BH3-only proteins in apoptosis at a glance.

Authors:  Lina Happo; Andreas Strasser; Suzanne Cory
Journal:  J Cell Sci       Date:  2012-03-01       Impact factor: 5.285

3.  Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors.

Authors:  Gregory J Gores; Scott H Kaufmann
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

4.  The N-end rule pathway counteracts cell death by destroying proapoptotic protein fragments.

Authors:  Konstantin I Piatkov; Christopher S Brower; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-05       Impact factor: 11.205

5.  Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein-induced lysosomal translocation of proapoptotic effectors is mediated by phosphofurin acidic cluster sorting protein-2 (PACS-2).

Authors:  Nathan W Werneburg; Steve F Bronk; Maria Eugenia Guicciardi; Laurel Thomas; Jimmy D Dikeakos; Gary Thomas; Gregory J Gores
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

6.  Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells.

Authors:  Husheng Ding; Jennifer S McDonald; Seongseok Yun; Paula A Schneider; Kevin L Peterson; Karen S Flatten; David A Loegering; Ann L Oberg; Shaun M Riska; Shengbing Huang; Frank A Sinicrope; Alex A Adjei; Judith E Karp; X Wei Meng; Scott H Kaufmann
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

Review 7.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

8.  Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance.

Authors:  Haiming Dai; Husheng Ding; X Wei Meng; Sun-Hee Lee; Paula A Schneider; Scott H Kaufmann
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

9.  Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis.

Authors:  Mary Speir; Kate E Lawlor; Stefan P Glaser; Gilu Abraham; Seong Chow; Adam Vogrin; Keith E Schulze; Ralf Schuelein; Lorraine A O'Reilly; Kylie Mason; Elizabeth L Hartland; Trevor Lithgow; Andreas Strasser; Guillaume Lessene; David C S Huang; James E Vince; Thomas Naderer
Journal:  Nat Microbiol       Date:  2016-02-24       Impact factor: 17.745

10.  Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.

Authors:  Joachim C Mertens; Christian D Fingas; John D Christensen; Rory L Smoot; Steven F Bronk; Nathan W Werneburg; Michael P Gustafson; Allan B Dietz; Lewis R Roberts; Alphonse E Sirica; Gregory J Gores
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.